AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
| ASTRAZENECA AB |
| ZYDUS PHARMACEUTICALS (USA) INC. |
| 22-2167 |
| August 30, 2022 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Opinions
We have the following opinions for this case:
| Description |
|---|
| ASTRAZENECA AB v. ZYDUS PHARMACEUTICALS (USA) INC. |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 25, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 9 ], ERROR: Appellant's motion does not include a Certificate of Interest. CORRECTION: For future relevant filings, please include a certificate of interest as required by FCR 47.4(b). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [880051] [ALK] [Entered: 10/25/2022 09:08 AM] |
| Filing 10 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 9 ] filed by Appellant Zydus Pharmaceuticals (USA) Inc. The opening brief is due 11/30/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [880049] [ALK] [Entered: 10/25/2022 09:07 AM] |
| Filing 9 MOTION of Appellant Zydus Pharmaceuticals (USA) Inc. to extend the time to 11/30/2022 to file brief. Service: 10/24/2022 by email. [879902] [22-2167] [Zhibin Li] [Entered: 10/24/2022 03:37 PM] |
| Filing 8 Docketing Statement for the Appellee AstraZeneca AB. Service: 09/13/2022 by email. [871475] [22-2167] [Jill MacAlpine] [Entered: 09/13/2022 03:32 PM] |
| Filing 7 Certificate of Interest for Appellee AstraZeneca AB. Service: 09/13/2022 by email. [871473] [22-2167] [Jill MacAlpine] [Entered: 09/13/2022 03:28 PM] |
| Filing 6 Entry of appearance for Charles E. Lipsey; John D. Livingstone; Jill K. MacAlpine; M. David Weingarten; Ryan O'Quinn; Matthew J. Hlinka as counsel for Appellee AstraZeneca AB. Service: 09/13/2022 by email. [871471] [22-2167] [Jill MacAlpine] [Entered: 09/13/2022 03:26 PM] |
| Filing 5 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 2 ], Doc No. [ # 3 ], Doc No. [ # 4 ], ERROR: Appellant's entry of appearance, certificate of interest, and docketing statement use a non-compliant signature format. CORRECTION: An electronic signature must follow the format prescribed by Fed. Cir. R. 25(g)(1)-(2). Please use a compliant signature format on future filings. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [871363] [ALK] [Entered: 09/13/2022 09:59 AM] |
| Filing 4 Docketing Statement for the Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 09/12/2022 by email. [871123] [22-2167] [Hugh Balsam] [Entered: 09/12/2022 11:17 AM] |
| Filing 3 Certificate of Interest for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 09/12/2022 by email. [871122] [22-2167] [Hugh Balsam] [Entered: 09/12/2022 11:15 AM] |
| Filing 2 Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; Alan B. Clement; Zhibin Li as counsel for Appellant Zydus Pharmaceuticals (USA) Inc.. Service: 09/12/2022 by email. [871121] [22-2167] [Hugh Balsam] [Entered: 09/12/2022 11:11 AM] |
| Filing 1 Appeal docketed. Received: 08/24/2022. [868848] Entry of Appearance is due on 09/13/2022. Certificate of Interest is due on 09/13/2022. Docketing Statement is due on 09/13/2022. Appellant's brief is due on 10/31/2022. [ALK] [Entered: 08/30/2022 09:53 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
